Target intelligence / Profile preview

tRNA splicing endonuclease subunit 34 (TSEN34)

Target
TSEN34
Molecular classification
Enzyme, Endoribonuclease, tRNA-splicing endonuclease subunit, RNA processing enzyme, Part of the tRNA-splicing endonuclease complex
01

Overview

TSEN34 is a catalytic subunit of the tRNA splicing endonuclease complex, required for accurate excision of introns from precursor tRNA molecules in eukaryotic cells. It cleaves at the 3′ splice site and also interacts with other complex subunits (notably TSEN2, TSEN15, and TSEN54) to facilitate tRNA maturation and efficient protein translation. TSEN34's function extends to mRNA 3′-end processing through association with additional factors, thus linking tRNA and mRNA processing pathways. Mutations in TSEN34 result in pontocerebellar hypoplasia (PCH) type 2C, leading to developmental delay, neurological deficits, and intellectual disability, demonstrating its essential role in brain development and cellular homeostasis. No drugs are currently known to directly target TSEN34, and any potential therapeutic modulation is limited by its critical cellular functions and associated safety risks.

Other names
SEN34LENG5SEN34LHsSen34Leukocyte receptor cluster member 5tRNA-intron endonuclease Sen34PCH2CCTD-3093M3.1
02

Mechanism of action

null

03

Biological functions

Catalyzes cleavage at the 3′ splice site of pre-tRNARemoves introns from precursor tRNAsSupports tRNA and mRNA maturationParticipates in pre-mRNA 3′-end processing via complex associationFacilitates protein translation by enabling mature tRNA production
04

Disease associations

Neurodevelopmental diseasePontocerebellar hypoplasia (PCH2), specifically Type 2CGeneral genetic disorders caused by TSEN34 mutations
05

Safety considerations

Genetic mutations in TSEN34 cause neurodevelopmental disorders, which limit any therapeutic targeting potential.As TSEN34 is essential for RNA splicing and protein synthesis, inhibition could lead to severe cellular dysfunction and toxicity
06

Biomarkers

TSEN34 gene mutation status

Beyond the preview

Go deeper on tRNA splicing endonuclease subunit 34 (TSEN34).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tRNA splicing endonuclease subunit 34 (TSEN34).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call